Acepodia

1 follower


Acepodia is using its proprietary bioconjugation technology to develop the next wave of off-the-shelf cell therapies for cancer.

Industries

Headquarters

Stage

Employees

Links

Sonny Hsiao
CEO, CSO, President & Co-Founder

Sonny Hsiao

Collapse
Harry Lam
CTO, EVP Technical Operations
Jennifer Wang
CQO, VP, Quality
Bill Mackin
Head, Regulatory Affairs
Michael Kurman
Head of Clinical Development
Kuang-Yi OuYang
Director Of Accounting